27.81
Maze Therapeutics Inc Borsa (MAZE) Ultime notizie
Will Maze Therapeutics Inc. stock rally after Fed decisionsQuarterly Trade Summary & Technical Analysis for Trade Confirmation - Trung tâm Dự báo KTTV quốc gia
Maze Therapeutics Inc. recovery potential after sell offJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
What is the fair value of Maze Therapeutics Inc. stock now2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com
Can Maze Therapeutics Inc. stock beat market expectations this quarterNew Guidance & Reliable Price Breakout Alerts - newser.com
Why Maze Therapeutics Inc. is moving todayQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com
Weiss Ratings Reaffirms "Sell (D)" Rating for Maze Therapeutics (NASDAQ:MAZE) - MarketBeat
Can a trend reversal in Maze Therapeutics Inc. lead to recovery2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
How to use a screener to detect Maze Therapeutics Inc. breakoutsWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com
Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Forecast to 2035 Featuring Amicus Therapeutics, Astellas, BioMarin, Maze Therapeutics, Oxyrane ParasailResearchAndMarkets.com - The AI Journal
Maze Therapeutics (NASDAQ:MAZE) Reaches New 1-Year HighWhat's Next? - MarketBeat
Maze Therapeutics Appoints Herve Hoppenot as Board Chairman - MarketScreener
What technical models suggest about Maze Therapeutics Inc.’s comeback2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Maze Therapeutics appoints Hervé Hoppenot as chairman of the board - Investing.com
Maze Therapeutics Appoints Hervé Hoppenot as Chairman - TipRanks
Maze Therapeutics appoints Hervé Hoppenot as board chairman - Investing.com India
Maze Therapeutics appoints Hervé Hoppenot as board chairman By Investing.com - Investing.com Australia
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors - GlobeNewswire
Detecting price anomalies in Maze Therapeutics Inc. with AI2025 Sector Review & Growth Focused Stock Pick Reports - newser.com
Predicting Maze Therapeutics Inc. trend using moving averages2025 Top Decliners & Verified Swing Trading Watchlist - newser.com
Maze Therapeutics (MAZE): Assessing Current Valuation Following a 78% Monthly Share Price Surge - Sahm
Maze Therapeutics (MAZE): Assessing Valuation After 78% 30-Day Share Price Surge - Yahoo Finance
What drives Maze Therapeutics Inc stock priceSupport Level Holds & Exceptional Profit Trading - earlytimes.in
Developing predictive dashboards with Maze Therapeutics Inc. dataWall Street Watch & Low Risk Entry Point Guides - newser.com
BTIG Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Maintains Target Price $37 - 富途牛牛
Maze Therapeutics Stock Just Shot Up 24% Pre-Market Today – Here’s What Happened - MSN
Goldman Sachs Group Inc. Makes New $145,000 Investment in Maze Therapeutics, Inc. $MAZE - Defense World
Maze Therapeutics (NASDAQ:MAZE) Stock Price Down 5.2%Should You Sell? - MarketBeat
Maze Therapeutics (NASDAQ:MAZE) Price Target Raised to $37.00 at JPMorgan Chase & Co. - MarketBeat
J.P. Morgan Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Raises Target Price to $37 - 富途牛牛
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):